141 related articles for article (PubMed ID: 15523670)
1. In support of fatty acid synthase (FAS) as a metabolic oncogene: extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells.
Menendez JA; Decker JP; Lupu R
J Cell Biochem; 2005 Jan; 94(1):1-4. PubMed ID: 15523670
[TBL] [Abstract][Full Text] [Related]
2. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
3. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
Furuta E; Pai SK; Zhan R; Bandyopadhyay S; Watabe M; Mo YY; Hirota S; Hosobe S; Tsukada T; Miura K; Kamada S; Saito K; Iiizumi M; Liu W; Ericsson J; Watabe K
Cancer Res; 2008 Feb; 68(4):1003-11. PubMed ID: 18281474
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway.
Swinnen JV; Heemers H; Deboel L; Foufelle F; Heyns W; Verhoeven G
Oncogene; 2000 Oct; 19(45):5173-81. PubMed ID: 11064454
[TBL] [Abstract][Full Text] [Related]
7. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid synthase: a metabolic oncogene in prostate cancer?
Baron A; Migita T; Tang D; Loda M
J Cell Biochem; 2004 Jan; 91(1):47-53. PubMed ID: 14689581
[TBL] [Abstract][Full Text] [Related]
10. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia.
Li JN; Mahmoud MA; Han WF; Ripple M; Pizer ES
Exp Cell Res; 2000 Nov; 261(1):159-65. PubMed ID: 11082286
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
12. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.
Menendez JA; Lupu R
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):346-57. PubMed ID: 16778562
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
Menendez JA; Lupu R
Arch Immunol Ther Exp (Warsz); 2004; 52(6):414-26. PubMed ID: 15577743
[TBL] [Abstract][Full Text] [Related]
16. A new targeting approach for breast cancer gene therapy using the human fatty acid synthase promoter.
Yan C; Wen-Chao L; Hong-Yan Q; Rui Z; Wei-Lin J; Hua H
Acta Oncol; 2007; 46(6):773-81. PubMed ID: 17653900
[TBL] [Abstract][Full Text] [Related]
17. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
[TBL] [Abstract][Full Text] [Related]
18. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
Weng MS; Ho CT; Ho YS; Lin JK
Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
[TBL] [Abstract][Full Text] [Related]
19. S14 protein in breast cancer cells: direct evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell growth.
Martel PM; Bingham CM; McGraw CJ; Baker CL; Morganelli PM; Meng ML; Armstrong JM; Moncur JT; Kinlaw WB
Exp Cell Res; 2006 Feb; 312(3):278-88. PubMed ID: 16300755
[TBL] [Abstract][Full Text] [Related]
20. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway.
Liu W; Furuta E; Shindo K; Watabe M; Xing F; Pandey PR; Okuda H; Pai SK; Murphy LL; Cao D; Mo YY; Kobayashi A; Iiizumi M; Fukuda K; Xia B; Watabe K
Breast Cancer Res Treat; 2011 Jul; 128(1):57-68. PubMed ID: 20665104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
